May 17th, 2018 | Pharmacy Pearls

This edition of Pharmacy Pearls presents an equivalent dose chart for those providers wishing to switch patients from Lyrica to gabapentin to save patients money. Additionally, it contains information about the incidence of reactions to the Shingrix vaccine, information about the costs of different testosterone dosage forms, and an update about a new follow-on rapid-acting…

Read More ›

April 2nd, 2018 | Pharmacy Pearls

As discussed in the last Pharmacy Pearls “Less Expensive Inhaler Now Available,” switching patients to RespiClick will help AHP realize significant savings as well as help patients with their out-of-pocket costs. The patient education handout below can be provided to patients making the switch to ensure that they use their new inhaler correctly.

March 5th, 2018 | Network NewsNewsPharmacy Pearls

Opportunity to offer a less expensive generic maintenance inhaler to patients: The first generic ICS/LABA inhaler, fluticasone/salmeterol RespiClick®, was FDA approved in 2017. Current review of inhaler prescribing suggests the potential to realize a minimum of $900,000 savings across the network in 2018 by switching 25% of brand ICS/LABA inhalers to the generic product. Additionally,…

Read More ›

January 11th, 2018 | NewsPharmacy Pearls

In light of the recent uptick in flu cases, please see the bulletin below regarding treatment and post-exposure prophylaxis. Prior to prescribing to lower risk patients, we encourage you to weigh the benefit of a 12 – 24 hour reduction in symptoms with the risks of GI intolerance and potential for antiviral resistance. Stay healthy!…

Read More ›

November 13th, 2017 | NewsPharmacy Pearls

This edition of Pharmacy Pearls is focused on the 2017-2018 influenza season. Prepared by Saloni Patel, PharmD, the Infectious Diseases PGY2 Pharmacy Resident at URMC, the newsletter details the available vaccine formulations and reviews information on Tamiflu, vaccination in older adults, high-dose vaccines, and vaccine immunity. As always, we are available for any medication-related questions…

Read More ›

September 11th, 2017 | NewsPharmacy Pearls

This edition of Pharmacy Pearls provides a brief introduction to the new Clinical Pharmacy Team at AHP as well as an overview of the medications approved for long-term weight loss with risks/benefits and guidance as to when you might choose one over another. There is also a section addressing the incredible cost difference between certain…

Read More ›

December 13th, 2016 | NewsPharmacy Pearls

This edition of Pharmacy Pearls is a new drug update bulletin that provides an overview of the soon-to-be released “generic” Lantus (Basaglar) as well as the newest option for basal insulin, Tresiba. It also includes a new column which provides quick tips for reducing out-of-pocket costs to patients with deductibles or donut holes.

December 8th, 2016 | Clinical ConnectionsNewsPharmacy Pearls

By Jineane Venci The number of patients subject to high out-of-pocket costs, either through donut holes or deductibles, is rapidly increasing. Here are some quick tips to reduce financial burden for patients requiring topical steroids: For super high potency ointments, gels, or lotions, prescribe generic betamethasone dipropionate over generic clobetasol propionate The cost per gram…

Read More ›

October 7th, 2016 | Pharmacy Pearls

This edition of the Pharmacy Pearls newsletter provides an overview of major updates to the CDC/ACIP 2016-2017 recommendations for influenza vaccinations. In light of the newly available generic Tamiflu, it also reviews CDC recommendations for antiviral treatment and prophylaxis. This newsletter was prepared with the assistance of URMC PGY-2 Infectious Diseases resident, Veronica Zafonte, PharmD.

September 14th, 2016 | Pharmacy Pearls